Stocks Health care PFSA

NASDAQ · Health care

Profusa, Inc. (PFSA)

It posted a net loss of $43M. In fiscal 2025 capital spending exceeded operating cash flow by $16.3M. At June 30, 2026 it held $719K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.

Watch PFSA in 60 seconds

What Profusa, Inc. does

Profusa, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PFSA.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Profusa, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 21, 2026
   Shareholder vote results 8-K
2. September 16, 2026
   Material agreement 8-K
3. September 15, 2026
   Other event 8-K
4. September 1, 2026
   Material agreement 8-K
5. August 31, 2026
   Stock exchange listing notice 8-K
6. August 28, 2026
   Proxy statement DEF 14A
7. August 21, 2026
   Material agreement 8-K
8. August 20, 2026
   Quarterly results 8-K
9. August 19, 2026
   Activist stake (5% or more) SCHEDULE 13D
10. August 19, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$151.80 versus -$9,100.78.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 4, 2026. Insider transactions on SEC

Insider trades

What the people running Profusa, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $25.3K and sold $153.2K worth of shares in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PFSA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 86,561 shares in total, about $146.3K at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PFSA

What does Profusa, Inc. do?

Profusa, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PFSA.

Is Profusa, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $43M.

When did Profusa, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the shareholder vote results from September 21, 2026.

Similar companies

Compare PFSA with

Compare PFSA with any company

Follow PFSA

Get an email when Profusa, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PFSA: get an email when it files

Where the numbers come from

Financial figures are the values Profusa, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.